Inventor · disambiguated record
Mark Krystal
Also filed as: KRYSTAL MARK · KRYSTAL MARK R
12 granted patents·5 pending applications·699 citations·filing 1990–2025
92Inventor score
Files withBRISTOL MYERS SQUIBB CO9VIIV HEALTHCARE UK NO 5 LTD3AVIRON INC1KRYSTAL MARK1MEDIMMUNE VACCINES INC1
Top patents by PatentIndex Score
17 records- 0195US7157447B2Bicyclic heterocycles as HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jan 2, 2007·30 cites·5 claims
- 0295US5166057ARecombinant negative strand rna virus expression-systemsSINAI SCHOOL MEDICINE·Filed 1990·Granted Nov 24, 1992·471 cites·35 claims
- 0394US7176196B2Bicyclic heterocycles as HIV integrase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Feb 13, 2007·35 cites·27 claims
- 0485US7511037B2N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitorBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 31, 2009·7 cites·4 claims
- 0585US5578473ARecombinant negative strand RNA virusAVIRON INC·Filed 1994·Granted Nov 26, 1996·91 cites·11 claims
- 0681US7276356B1Recombinant negative strand RNA virus expression systems and vaccinesMEDIMMUNE VACCINES INC·Filed 2000·Granted Oct 2, 2007·7 cites·7 claims
- 0781US7030140B2Substituted benzimidazole antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 18, 2006·12 cites·1 claims
- 0868US10407490B2Polypeptides targeting HIV fusionBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 10, 2019·1 cites·12 claims
- 0966US6908936B2Substituted benzimidazole antiviral agentsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jun 21, 2005·3 cites·4 claims
- 1061US5837852ACapped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonucleaseBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Nov 17, 1998·28 cites·14 claims
- 1161US5691189ASaccharomyces cerevisiae expressing M2 protein of influenza A virusBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Nov 25, 1997·14 cites·10 claims
- 1257US2025250328A1Antigen Binding ProteinsVIIV HEALTHCARE UK NO 5 LTD·Filed 2025·Application pending·0 cites
- 1356US11155602B2Polypeptides targeting HIV fusionVIIV HEALTHCARE NO 5 LTD·Filed 2019·Granted Oct 26, 2021·0 cites·7 claims
- 1450US2006058286A1Methods of treating HIV infectionKRYSTAL MARK·Filed 2005·Application pending·0 cites
- 1542US2014356863A1Methods for determining the susceptibility of a virus to an attachment inhibitorBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 1641US2019030025A1Fostemsavir for use in heavily treatment-experienced hiv-1 infected individualsVIIV HEALTHCARE UK NO 5 LTD·Filed 2017·Application pending·0 cites
- 1739US2024239877A1Antigen binding polypeptidesVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Krystal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →